Oxford Biomedica

Oxford Biomedica

MA - Bedford
CDMO (Contract Manufacturing)1 H-1B visas (FY2023)
WebsiteLinkedInCareers Page

Focus: CDMO, AAV manufacturing

Oxford Biomedica is a life sciences company focused on CDMO, AAV manufacturing.

Gene Therapy
Funding Stage
PUBLIC
Employees
1001-5000
Open Jobs
0

Pipeline & Clinical Trials

Phase 1
Clinical Trials (1)
NCT01678872A Follow-up Study to Evaluate the Safety of RetinoStat® in Patients With Age-Related Macular Degeneration
Phase 1
Subretinally injected RetinoStat
Age Related Macular Degeneration
Phase 1
Clinical Trials (1)
NCT01301443Phase I Dose Escalation Safety Study of RetinoStat in Advanced Age-Related Macular Degeneration (AMD)
Phase 1
Phase 1/2
Clinical Trials (1)
NCT01856439Long Term Safety and Efficacy Study of ProSavin in Parkinson's Disease
Phase 1/2
Phase 1/2
Clinical Trials (1)
NCT00627588Phase I/II Study of the Safety, Efficacy and Dose Evaluation of ProSavin for the Treatment of Bilateral Idiopathic Parkinson's Disease
Phase 1/2
Phase 2
Clinical Trials (1)
NCT00448409Activity of TroVax® Alone vs. TroVax® Plus GM-CSF in Patients With Prostate Cancer
Phase 2
Phase 2
Clinical Trials (1)
NCT01194960TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)
Phase 2
Phase 2
Clinical Trials (1)
NCT00521274Study of Trovax® Plus Docetaxel Versus Docetaxel Alone in Patients With Progressive Hormone Refractory Prostate Cancer
Phase 2
Phase 2
Clinical Trials (1)
NCT00325507Safety and Biological Activity of TroVax® Vaccine Given With IL-2 in Renal Cell Carcinoma
Phase 2
Phase 2
Clinical Trials (1)
NCT01556841The Activity of TroVax® Versus Placebo in Relapsed Asymptomatic Ovarian Cancer
Phase 2
Phase 2
Clinical Trials (1)
NCT00083941A Study of TroVax Vaccine Given in Conjunction With IL-2 for Treatment of Stage IV Renal Cell Cancer
Phase 2
Phase 2
Clinical Trials (1)
NCT00259844Effect of TroVax in Patients Having Colorectal Cancer With Liver Metastases Removed
Phase 2
Phase 2
Clinical Trials (1)
NCT00445523Safety Study of TroVax Alone vs. TroVax Plus Interferon Alpha in Patients With Renal Cancer
Phase 2
Phase 3
Clinical Trials (1)
NCT00397345TroVax Renal Immunotherapy Survival Trial
Phase 3

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Founded: 2024
Portfolio: 13 clinical trials
Top TAs: Oncology
H-1B (2023): 1 approval
Therapeutic Area Focus
Oncology
1 pipeline
Marketed
Pipeline

Hiring Trend

Stable
0
Open Roles
+0
Added
-0
Filled/Removed

Based on last 3 crawl cycles

Visa Sponsorship

Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate

Source: USCIS H-1B Employer Data Hub